Frontlight ResearchEarly access
Trial site
Nanchong Central Hospital
- 12running trials
- 4closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Colorectal cancer3 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Alzheimer disease1 trial
- Diabetic foot ulcer1 trial
- High blood pressure1 trial
- Migraine1 trial
- Thyroid cancer1 trial
- Phase
- Phase 34 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed4 trials
- Lead sponsor
- Nanchong Central Hospital6 trials
- Eli Lilly and Company2 trials
- Beijing Tiantan Hospital1 trial
- Biotheus Inc.1 trial
- Dongzhimen Hospital, Beijing1 trial
- and 5 more
Running trials
Recruiting
Short-term SCS for Refractory Diabetic Foot Neuropathic Pain
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Diabetic foot ulcer1 recruiting
- Migraine1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Completed
Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026